Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung

7680675730018 CH-67573 Pulver
Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung
Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung
Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/03/2022
Summary of Product Characteristics
Français
04/03/2022
Summary of Product Characteristics
Italien
04/03/2022

Detailed composition

Substance Quantity Type Category
PRC
100.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Reimbursement information

Public price
CHF 381.95
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2020

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
67573
Drug name
Anidulafungin Pfizer 100 mg, Pulver zur Herstellung einer Infusionslösung
Galenic form
PULP
ATC Code
J02AX06
Authorization status
Z
Authorization category
Category C
Dispensing category
A
First authorization
03/09/2019
Authorization expiration date
31/12/9999
IT Number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Package details

Description (FR)
ANIDULAFUNGIN Pfizer subst sèche 100 mg flac
Description (DE)
ANIDULAFUNGIN Pfizer Trockensub 100 mg Durchstf
Market launch
03/09/2019
Narcotic (BTM)
No

Original drug

Ecalta, Pulver zur Herstellung einer Infusionslösung
GTIN: 7680583250035
CHF 442.80
View original